Clinical Trial of the Phytoestrogen-rich Herb, Pueraria mirifica as a Crude Drug in the Treatment of Symptoms in Menopausal Women

Verasing Muangman, Wichai Cherdshewasart


     The clinical trial to evaluate the estrogenic effects of the crude drug derived from dry powder of a phytoestrogen-rich Thai herb Pueraria mirifica (White Kwao Krua) in five female volunteers with menopausal symptoms showed that the crude drug clearly improved the signs and symptoms related to menopause such as, hot flushes, frustration, sleep disorder, skin dryness, high blood cholesterol, oligomenorrhoea and amenorrhoea, with no change in the blood cells, liver and kidney functions, as well as other physiological status after four months of treatment. In four volunteers, treatments were continued to complete the one-year test period with half the dose and was found to maintain their satisfied menopausal relief status. The crude drug dosage was administered at 200 mg daily for three weeks a month during the first four months of treatment and 200 mg every other day for 20 days per month for the remaining of eight months. These doses were effective and safe as phytoestrogen treatment of menopausal symptoms.


Full Text:


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.


  • There are currently no refbacks.

Contact address:
Amornrat Sangkaew
Editorial Office Secretary
SiMR Bldg., 2nd Fl., Room No.207, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Tel: +662 419 2884 | Fax: +662 411 0593 | Email: